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ETHICS & PRICING 
IN THE PHARMACEUTICAL INDUSTRY
TURING PHARMACEUTICALS & DARAPRIM, 






a global issue resulting from 
parasitic infection
inhibits dihydrofolate reductase, 
essential for nucleic acid anabolism
TURING PHARMACEUTICALS
and daraprim, a WHO essential 
medicine & its patent
JUSTIFICATIONS
DARAPRIM
Other examples of price gouging, 
differences between countries.
OTHER EXAMPLES
Other examples of price gouging, 
differences between countries.






How a typical business functions in 
capitalism vs a pharmaceutical company
The stages of drug development, 
cost of R&D, clinical trials.
VALEANT PHARMACEUTICALS




A quick dive into ethical theory and 
how it applies to this topic
US POLICY
Suggestions for Biden, Historical 
policy stances.
an infection caused by a 
single-celled parasite called 
Toxoplasma gondii. 
People with severely weakened 
immune systems, such as individuals 
with HIV/AIDS, those receiving  
chemotherapy
Treated with a combination of 
drugs such as pyrimethamine and 
sulfadiazine.
TOXOPLASMOSIS
















Founded Feb 24, 2015 
by Martin Shkreli. 
Retrophin, Vecamyl and 
Daraprim which had 




Turing increased the 
price of Daraprim from 
$13.50 a pill to $750
The 5,455% Increase
JUSTIFICATIONS
01 Profit would be allocated to research and development of toxoplasmosis treatment
02 Daraprim is underpriced relative to its “life-saving” peers.
1996: $21  
2020: $275
MORE EXAMPLES OF PRICE GOUGING IN THE INDUSTRY
INSULIN DOXYCYCLINE
2013: $20  
2014: $1,849
DIGOXIN EPI-PEN
2012: $0.11  
2014: $1.10
2007: $50  
2020: $600
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Works: Competition and Fluctuation 
in Demand
Goal: Sell Product to Satisfy Demand
CAPITALISM VS. MONOPOLY
Theory suggests that an 
action is good or bad 
depending on its outcome
Profit is a positive outcome, 
but the cost of the human life 
is a burden that outweighs 
the benefits
Theory is based on treating 
humanity never simply as a 
means to an end.
MORAL RESPONSIBILITY & BIG PHARMA
CONSEQUENTIALIST DEONTOLOGICAL
Raising drug prices for profit 
treats patients as a means to 
an end as their demand is 
inelastic. 
TRUMP, BIDEN & BIG PHARMA
- Both Biden & Trump have promised 
to slash drug prices
- Trump: accelerating approvals for 
generic drugs and pressuring big 
pharma  to lower Medicare pricing.
- (Mylan & Teva issues) 
- Biden: calling for allowing Medicare 
to negotiate discounted drug prices. 
- Donated $647,000 to Trump’s 
re-election and $2.5 million to Biden
YOUR THOUGHTS?
